RSV vs. rhinovirus bronchiolitis: difference in nasal airway microRNA profiles and NFκB signaling

Pediatr Res. 2018 Mar;83(3):606-614. doi: 10.1038/pr.2017.309. Epub 2018 Jan 17.


BackgroundAlthough rhinovirus infection is associated with increased risks of acute and chronic respiratory outcomes during childhood compared with respiratory syncytial virus (RSV), the underlying mechanisms remain unclear. We aimed to determine the differences in nasal airway microRNA profiles and their downstream effects between infants with rhinovirus and RSV bronchiolitis.MethodsAs part of a multicenter cohort study of infants hospitalized for bronchiolitis, we examined nasal samples obtained from 16 infants with rhinovirus and 16 infants with RSV. We tested nasal airway samples using microarrays to profile global microRNA expression and determine the predicted regulation of targeted transcripts. We also measured gene expression and cytokines for NFκB pathway components.ResultsBetween the virus groups, 386 microRNAs were differentially expressed (false discovery rate (FDR)<0.05). In infants with rhinovirus, the NFκB pathway was highly ranked as a predicted target for these differentially expressed microRNAs compared with RSV. Pathway analysis using measured mRNA expression data validated that rhinovirus infection had upregulation of NFκB family (RelA and NFκB2) and downregulation of inhibitor κB family. Infants with rhinovirus had higher levels of NFκB-induced type-2 cytokines (IL-10 and IL-13; FDR<0.01).ConclusionIn infants with bronchiolitis, rhinovirus and RSV infections had different nasal airway microRNA profiles associated with NFκB signaling.

Publication types

  • Comparative Study
  • Multicenter Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Bronchiolitis / genetics
  • Bronchiolitis / physiopathology*
  • Bronchiolitis / virology
  • Cytokines / metabolism
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • MicroRNAs / genetics*
  • NF-kappa B / metabolism*
  • Nasopharynx / virology
  • Picornaviridae Infections / genetics
  • Picornaviridae Infections / physiopathology*
  • Prospective Studies
  • Respiratory Syncytial Virus Infections / genetics
  • Respiratory Syncytial Virus Infections / physiopathology*
  • Respiratory Syncytial Virus, Human
  • Rhinovirus
  • Signal Transduction


  • Cytokines
  • MicroRNAs
  • NF-kappa B